Who Paid My Doc
BRACAnalysis CDx
Device Germline Dna Sequencing Hereditary Cancer And Rearrangement Analysis
General payments
$134,837
Research payments
$0
Through program year 2021, $134,837 in general payments and $0 in research payments were reported against BRACAnalysis CDx (Germline Dna Sequencing Hereditary Cancer And Rearrangement Analysis).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $67,842 | 1,430 |
| 2020 | General | $66,303 | 817 |
| 2019 | General | $693 | 19 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
2,266 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.